Publication | Closed Access

Eicosapentaenoic acid (EPA) from highly concentrated n−3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability

Cardiovascular DiseaseBiochemistryMedicineEicosapentaenoic AcidVascular BiologyHigher Plaque EpaLipoprotein MetabolismPharmacologyAtherosclerosisDyslipidemiaDecreased Plaque Inflammation